# SGS North America Inc – FDA Inspection, Jun 23, 2017

Source: https://www.keypedia.com/records/fda_inspections/sgs-north-america-inc/f98c4693-9fdb-4f43-9d08-0ac39dabe747
Source feed: FDA_Inspections

> FDA inspection 1015515 of SGS North America Inc, June 23, 2017. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 211. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1015515
- Company Name: SGS North America Inc
- Inspection Date: 2017-06-23
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Generic Drug Evaluation
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 2

## Related Documents

- [FDA Inspection 1239166 - 2024-05-08](https://www.keypedia.com/records/fda_inspections/sgs-north-america-inc/2948dad6-d9c5-4c63-9147-304152e6a28d)

## Related Officers

- [Company Rep](https://www.keypedia.com/people/jonathan-w-chapman/5b5134c3-71f9-4212-9429-4554d91e8aa9)

Company: https://www.keypedia.com/companies/sgs-north-america-inc/9c5ff5d3-187a-438c-a428-ea2d0412e027

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c